Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia
Clinical trial NCT05863234 · RECRUITING
Trial details
- NCT number
- NCT05863234
- Sponsor
- Hiroshima University Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-21
- Primary completion
- 2026-03-31
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.